Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.210
-0.040 (-1.78%)
Jun 4, 2026, 4:10 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 182.8 million as of June 3, 2026. Its market cap has decreased by -50.55% in one year.
Market Cap
182.80M
Enterprise Value
157.82M
Revenue
407.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.21
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 182.80M, an increase of 300.36%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 182.80M | -27.65% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 44.77B |
| Sigma Healthcare | 33.01B |
| Pro Medicus | 16.72B |
| Sonic Healthcare | 9.24B |
| Healius | 232.36M |
| Orthocell | 204.19M |
| EBR Systems | 202.75M |
| SDI Limited | 161.66M |